
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 979 | 893 | 1003 | 1123 | 1600 | - |
Fund Return | -2.06% | -10.72% | 0.3% | 3.95% | 9.85% | - |
Place in category | 163 | 319 | 488 | 149 | 172 | - |
% in Category | 29 | 56 | 87 | 32 | 41 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Harbor Capital Appreciation Instl | 15.65B | -0.20 | 14.38 | 15.22 | ||
Harbor Capital Appreciation Retirem | 9.63B | -0.19 | 14.47 | - | ||
Harbor International Institutional | 2.67B | 7.59 | 5.90 | 4.31 | ||
Harbor Small Cap Value Instl | 1.72B | -3.22 | 4.76 | 8.25 | ||
Harbor Small Cap Growth Instl | 1.02B | -2.08 | 3.86 | 8.76 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Explorer Adm | 18.36B | -2.10 | 3.52 | 9.47 | ||
Vanguard Small Cap Growth Index Adm | 14.11B | -2.31 | 4.38 | 8.29 | ||
Neuberger Berman Genesis R6 | 4.32B | -2.79 | 3.60 | 9.16 | ||
T. Rowe Price Instl Small-Cap Stock | 4.15B | -0.08 | 3.93 | 9.50 | ||
T. Rowe Price QM US Small-Cap Gr Eq | 4.1B | -1.75 | 5.76 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Ascendis Pharma AS | US04351P1012 | 4.07 | 145.63 | +5.39% | |
Comfort Systems | US1999081045 | 3.67 | 324.58 | +3.61% | |
FTAI Aviation | KYG3730V1059 | 3.46 | 105.58 | +8.08% | |
Casella | US1474481041 | 2.74 | 107.31 | -1.50% | |
ITT | US45073V1089 | 2.61 | 133.87 | -0.75% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review